Package 62332-502-03

Brand: olopatadine hydrochloride

Generic: olopatadine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 62332-502-03
Digits Only 6233250203
Product NDC 62332-502
Description

1 BOTTLE, PLASTIC in 1 CARTON (62332-502-03) / 2.5 mL in 1 BOTTLE, PLASTIC

Marketing

Marketing Status
Marketed Since 2019-04-29
Brand olopatadine hydrochloride
Generic olopatadine hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "fb3ef8a7-46e3-4d8e-83df-117674d1c8aa", "openfda": {"upc": ["0362332502035"], "unii": ["2XG66W44KF"], "rxcui": ["1111343"], "spl_set_id": ["dbcdf10c-5adb-4d48-97ce-f4b82c6bc77d"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (62332-502-03)  / 2.5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "62332-502-03", "marketing_start_date": "20190429"}], "brand_name": "OLOPATADINE HYDROCHLORIDE", "product_id": "62332-502_fb3ef8a7-46e3-4d8e-83df-117674d1c8aa", "dosage_form": "SOLUTION/ DROPS", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Inhibitor [EPC]"], "product_ndc": "62332-502", "generic_name": "olopatadine hydrochloride", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OLOPATADINE HYDROCHLORIDE", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA209420", "marketing_category": "ANDA", "marketing_start_date": "20190429", "listing_expiration_date": "20261231"}